Communication in Children with or Without Biomedical Conditions: Speech and Language Profile, Related Outcomes and Articulation Treatment with Ultrasound

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The study is a prospective randomized controlled procedure to investigate the effect of ultrasound in articulation training and also the effect of treatment intensity in this mode of therapy. Targeted subjects are children with brain tumor or cleft palate with articulation errors which visualization of lingual movement using ultrasound may facilitate their acquisition of the sounds misarticulated. Subjects would be randomized to two groups of high and low treatment intensity, with stratification to the groups by disorders, age and gender whenever possible. Participants will be randomly assigned to either the treatment group or a waitlist control group in a 1:1 ratio.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 5
Maximum Age: 12
Healthy Volunteers: f
View:

• No syndromes or obvious dysmorphic features; No language disorders associated with biomedical conditions (e.g., cerebral palsy, autism spectrum disorder); No oronasal fistula identified in oral examination or diagnosed velopharyngeal insufficiency; Hearing thresholds between 0 to 25 dB in at least one ear, with no hearing loss exceeding 50 dB in the other; Cantonese as the first language

Locations
Other Locations
Hong Kong Special Administrative Region
Hong Kong Children's Hospital and Child Assessment Centre of The Duchess of Kent Children's Hospital
RECRUITING
Hong Kong
Contact Information
Primary
Oi Yan Yoyo Yiu
h0501126@connect.hku.hk
5741 3431
Time Frame
Start Date: 2023-11-11
Estimated Completion Date: 2025-06-30
Participants
Target number of participants: 60
Treatments
Other: case group
Dose comparison (same intervention)
Other: Control Group
Dose comparison (same intervention)
Related Therapeutic Areas
Sponsors
Leads: The University of Hong Kong

This content was sourced from clinicaltrials.gov